| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of evidence for an etiologic role for Epstein-Barr virus in neoplasms of the lung and pleura
|
|
|
1996
|
16 |
1 |
p. 106-
1 p.
|
artikel
|
| 2 |
A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma
|
|
|
1996
|
16 |
1 |
p. 125-126
2 p.
|
artikel
|
| 3 |
Adenocarcinoma of the lung with aspergillus in tumor necrotic area
|
|
|
1996
|
16 |
1 |
p. 114-
1 p.
|
artikel
|
| 4 |
Adenoid cystic carcinoma of the left main bronchus mimicking MacLeod's syndrome
|
|
|
1996
|
16 |
1 |
p. 117-
1 p.
|
artikel
|
| 5 |
Analysis of serum CYFR21-1 by immunoradiometric assay in patients with non-small cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 113-114
2 p.
|
artikel
|
| 6 |
Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 116-
1 p.
|
artikel
|
| 7 |
Anti-CEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancer
|
|
|
1996
|
16 |
1 |
p. 117-
1 p.
|
artikel
|
| 8 |
Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer
|
|
|
1996
|
16 |
1 |
p. 119-
1 p.
|
artikel
|
| 9 |
A phase II study of cisplatin, vindesine and continously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 123-124
2 p.
|
artikel
|
| 10 |
A phase II study of mitomycin C, vindesine and cisplatin combined with alpha interferon in advanced non-small cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 124-
1 p.
|
artikel
|
| 11 |
A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: A cancer and leukemia group B study
|
|
|
1996
|
16 |
1 |
p. 121-
1 p.
|
artikel
|
| 12 |
Assessment of the accuracy of diagnostic chest CT scanning. Impact on lung cancer management
|
|
|
1996
|
16 |
1 |
p. 112-
1 p.
|
artikel
|
| 13 |
Association between the p21 codon 31 A1 (arg) allele and lung cancer
|
|
|
1996
|
16 |
1 |
p. 108-
1 p.
|
artikel
|
| 14 |
Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma: Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen
|
|
|
1996
|
16 |
1 |
p. 110-
1 p.
|
artikel
|
| 15 |
Autopsy findings in small cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 115-
1 p.
|
artikel
|
| 16 |
bcl-2 and p53 protein expression in non-small cell lung cancers: Correlation with survival time
|
|
|
1996
|
16 |
1 |
p. 114-
1 p.
|
artikel
|
| 17 |
Bilateral patellar metastases as the clinical presentation of bronchogenic adenocarcinoma
|
|
|
1996
|
16 |
1 |
p. 115-
1 p.
|
artikel
|
| 18 |
Bronchioloalveolar carcinoma
|
|
|
1996
|
16 |
1 |
p. 115-116
2 p.
|
artikel
|
| 19 |
Calendar
|
|
|
1996
|
16 |
1 |
p. 103-104
2 p.
|
artikel
|
| 20 |
Cancer genetics and cell andmolecular biology: Is this the way forward?
|
|
|
1996
|
16 |
1 |
p. 109-
1 p.
|
artikel
|
| 21 |
Carinal resection and reconstruction double-barrelled type for bronchogenic and metastatic carcinoma
|
|
|
1996
|
16 |
1 |
p. 118-
1 p.
|
artikel
|
| 22 |
CD44v6 expression in primary bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma
|
|
|
1996
|
16 |
1 |
p. 110-111
2 p.
|
artikel
|
| 23 |
Chemotherapy for advanced disease: How to raise enthusiasm
|
|
|
1996
|
16 |
1 |
p. 123-
1 p.
|
artikel
|
| 24 |
Cisplatin-vinorelbine combination chemotherapy in locally advanced non-small cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 124-
1 p.
|
artikel
|
| 25 |
Clinical implications of prophylactic irradiation of the ipsilateral hilum and mediastinum for clinical stage NO non-small cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 126-
1 p.
|
artikel
|
| 26 |
Combination chemotherapy for advanced lung cancer: Survival differences between histological types and implications for prevention in Thailand
|
|
|
1996
|
16 |
1 |
p. 122-123
2 p.
|
artikel
|
| 27 |
Combined chemotherapy in pleurectomized malignant pleural mesothelioma patients
|
|
|
1996
|
16 |
1 |
p. 123-
1 p.
|
artikel
|
| 28 |
Detection of human papilloma virus (HPV) and K-ras mutations in human lung carcinomas
|
|
|
1996
|
16 |
1 |
p. 108-109
2 p.
|
artikel
|
| 29 |
Economic considerations in the care of lung cancer patients
|
|
|
1996
|
16 |
1 |
p. 127-
1 p.
|
artikel
|
| 30 |
Editorial Board
|
|
|
1996
|
16 |
1 |
p. IFC-
1 p.
|
artikel
|
| 31 |
Effects of residential mobility on individual versus population risk of radon-related lung cancer
|
|
|
1996
|
16 |
1 |
p. 106-
1 p.
|
artikel
|
| 32 |
Endobronchial extramedullary plasmacytoma. Report of one case
|
Terzi, A.
|
|
1996
|
16 |
1 |
p. 95-100
6 p.
|
artikel
|
| 33 |
Endobronchial ultrasound—A new perspective in bronchoscopy
|
|
|
1996
|
16 |
1 |
p. 112-113
2 p.
|
artikel
|
| 34 |
Endoscopic brachytherapy
|
|
|
1996
|
16 |
1 |
p. 126-
1 p.
|
artikel
|
| 35 |
Expression and autoregulation of transforming growth factor α receptor mRNA in small-cell lung cancer cell lines
|
|
|
1996
|
16 |
1 |
p. 107-
1 p.
|
artikel
|
| 36 |
Expression of E-selectin, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 in non-small-cell lung carcinoma
|
|
|
1996
|
16 |
1 |
p. 112-
1 p.
|
artikel
|
| 37 |
Expression of vitamin D receptor in lung cancer
|
|
|
1996
|
16 |
1 |
p. 109-
1 p.
|
artikel
|
| 38 |
Fine-needle aspiration as the initial diagnostic modality in malignant lung disease
|
|
|
1996
|
16 |
1 |
p. 116-
1 p.
|
artikel
|
| 39 |
Genetic abnormality at the 1p32 locus in metastasis of lung cancer
|
|
|
1996
|
16 |
1 |
p. 109-
1 p.
|
artikel
|
| 40 |
High dose rate brachytherapy for the local control of endobronchial carcinoma following external irradiation
|
|
|
1996
|
16 |
1 |
p. 124-125
2 p.
|
artikel
|
| 41 |
High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: Diagnostic value, relation to serum neuron specific enolase, and staging
|
|
|
1996
|
16 |
1 |
p. 115-
1 p.
|
artikel
|
| 42 |
HLA class I and class II expression of cancer cells in lung adenocarcinoma and the influence of IFN-gamma
|
|
|
1996
|
16 |
1 |
p. 115-
1 p.
|
artikel
|
| 43 |
HLA class I and neuroendocrine antigen expression in multidrug resistant small cell lung carcinoma cell lines
|
|
|
1996
|
16 |
1 |
p. 122-
1 p.
|
artikel
|
| 44 |
Human lung cancer cells endogenously expressing mutant p53 process and present the mutant epitope and are lysed by mutant-specific cytotoxic T lymphocytes
|
|
|
1996
|
16 |
1 |
p. 109-
1 p.
|
artikel
|
| 45 |
Ifosfamide combined with toremifene in the treatment of non-small cell lung cancer
|
Salomaa, Eija-Riitta
|
|
1996
|
16 |
1 |
p. 75-80
6 p.
|
artikel
|
| 46 |
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: A phase I study
|
|
|
1996
|
16 |
1 |
p. 122-
1 p.
|
artikel
|
| 47 |
Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma
|
|
|
1996
|
16 |
1 |
p. 111-112
2 p.
|
artikel
|
| 48 |
Immunohistochemical detection of bcl-2 protein in adenocarcinoma and Non-Neoplastic cellular compartments of the lung
|
|
|
1996
|
16 |
1 |
p. 111-
1 p.
|
artikel
|
| 49 |
Immunohistochemical examination of fucosylceramide expression in lung adenocarcinomas
|
|
|
1996
|
16 |
1 |
p. 109-
1 p.
|
artikel
|
| 50 |
Induction of benign and malignant pulmonary tumours in mice with benzo(a)pyrene
|
|
|
1996
|
16 |
1 |
p. 107-
1 p.
|
artikel
|
| 51 |
Interleukin-2 receptors in pulmonary adenocarcinoma tissue
|
Yano, Tokujiro
|
|
1996
|
16 |
1 |
p. 13-19
7 p.
|
artikel
|
| 52 |
Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers
|
|
|
1996
|
16 |
1 |
p. 111-
1 p.
|
artikel
|
| 53 |
Letter to the editor
|
Krarup-Hansen, Andres
|
|
1996
|
16 |
1 |
p. 101-102
2 p.
|
artikel
|
| 54 |
Lung cancer in West Sweden 1976–1985: A study of trends and survival with special reference to surgical treatment
|
|
|
1996
|
16 |
1 |
p. 120-
1 p.
|
artikel
|
| 55 |
Lung cancer mortality among males of Catalonia and Spain compared with other European countries between 1975 and 1987–1989
|
|
|
1996
|
16 |
1 |
p. 107-108
2 p.
|
artikel
|
| 56 |
Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County
|
|
|
1996
|
16 |
1 |
p. 107-
1 p.
|
artikel
|
| 57 |
Lung cancer, smoking, and environment: A cohort study of the Danish population
|
|
|
1996
|
16 |
1 |
p. 106-
1 p.
|
artikel
|
| 58 |
Lung cancer with visual loss
|
|
|
1996
|
16 |
1 |
p. 113-
1 p.
|
artikel
|
| 59 |
Lung tumours immunoreactive for parathyroid hormone related peptide: Analysis of serum calcium levels and tumour type
|
|
|
1996
|
16 |
1 |
p. 117-
1 p.
|
artikel
|
| 60 |
Mainstem bronchial sleeve resection with pulmonary preservation
|
|
|
1996
|
16 |
1 |
p. 118-119
2 p.
|
artikel
|
| 61 |
Massive haemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus
|
|
|
1996
|
16 |
1 |
p. 126-
1 p.
|
artikel
|
| 62 |
Meat consumption and risk of lung cancer; A case-control study from Uruguay
|
|
|
1996
|
16 |
1 |
p. 105-
1 p.
|
artikel
|
| 63 |
Membrane-bound (MUC1) and secretory (MUC2, MUC3, and MUC4) mucin gene xpression in human lung cancer
|
|
|
1996
|
16 |
1 |
p. 111-
1 p.
|
artikel
|
| 64 |
Microsatellite alterations in bronchial and sputum specimens of lung cancer patients
|
|
|
1996
|
16 |
1 |
p. 114-
1 p.
|
artikel
|
| 65 |
Modification of tumor suppressor gene expression and induction of apoptosis in non-small cell lung cancer (NSCLC) with an adenovirus vector expressing wildtype p53 and cisplatin
|
|
|
1996
|
16 |
1 |
p. 108-
1 p.
|
artikel
|
| 66 |
Multiple primary lung tumors: A review of the radiological findings
|
|
|
1996
|
16 |
1 |
p. 117-
1 p.
|
artikel
|
| 67 |
Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic Stage IIIA (N2): Analysis of Cancer and Leukemia Group B Protocol 8935
|
|
|
1996
|
16 |
1 |
p. 125-
1 p.
|
artikel
|
| 68 |
Pharmacokinetics, biodistribution and dosimetry of anti-NCAM monoclonal antibody RNL-1 and its fragments in experimental lung cancer
|
|
|
1996
|
16 |
1 |
p. 111-
1 p.
|
artikel
|
| 69 |
Phase I dose-escalation trial of gemcitabine and cisplatin for advanced non-small-cell lung cancer: Usefulness of mathematic modeling to determine maximum-tolerable dose
|
|
|
1996
|
16 |
1 |
p. 121-
1 p.
|
artikel
|
| 70 |
Phase II study of alternating doses of vinorelbine in combination with cisplatin for non-small cell lung cancer (NSCLC): a disappointing experience
|
Westeel, Virginie
|
|
1996
|
16 |
1 |
p. 61-73
13 p.
|
artikel
|
| 71 |
Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: A Japanese cooperative study
|
|
|
1996
|
16 |
1 |
p. 123-
1 p.
|
artikel
|
| 72 |
Phase I study of paclitaxel (TaxolR) and ifosfamide in previously untreated patients with advanced non-small-cell lung cancer. A study of the National Cancer Institute of Canada Clinical Trials Group
|
|
|
1996
|
16 |
1 |
p. 122-
1 p.
|
artikel
|
| 73 |
Plasma transforming growth factor-β1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker
|
Kong, Feng-Ming
|
|
1996
|
16 |
1 |
p. 47-59
13 p.
|
artikel
|
| 74 |
Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 113-
1 p.
|
artikel
|
| 75 |
Preoperative chemoradiotherapy for stage III unresectable non-small cell lung cancer: Results of a phase II study
|
|
|
1996
|
16 |
1 |
p. 127-
1 p.
|
artikel
|
| 76 |
Preoperative chemotherapy for stage IIIa non-small cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 125-
1 p.
|
artikel
|
| 77 |
Primary hemangiosarcoma of the mediastinum
|
Kardamakis, Dimitrios
|
|
1996
|
16 |
1 |
p. 81-86
6 p.
|
artikel
|
| 78 |
Primary lung cancer in Mexico city: A report of 1019 cases
|
|
|
1996
|
16 |
1 |
p. 105-
1 p.
|
artikel
|
| 79 |
P21 RNA and protein expression in non-small cell lung carcinomas: Evidence of p53-independent expression and association with tumoral differentiation
|
|
|
1996
|
16 |
1 |
p. 110-
1 p.
|
artikel
|
| 80 |
Prognostic factors and long-term survival of non-resected cases with non-small cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 114-
1 p.
|
artikel
|
| 81 |
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC)
|
Borges, M.
|
|
1996
|
16 |
1 |
p. 21-33
13 p.
|
artikel
|
| 82 |
Prognostic factors in resected non-small cell lung cancer: an immunohistochemical study of 39 cases
|
Kwa, H.B.
|
|
1996
|
16 |
1 |
p. 35-45
11 p.
|
artikel
|
| 83 |
Prognostic value and clinicopathological correlation of thrombomodulin in squamous cell carcinoma of the human lung
|
|
|
1996
|
16 |
1 |
p. 117-118
2 p.
|
artikel
|
| 84 |
Prognostic value of angiogenesis in operable non-small cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 113-
1 p.
|
artikel
|
| 85 |
Prognostic value of MIB-1 in neuroendocrine tumours of the lung
|
|
|
1996
|
16 |
1 |
p. 116-117
2 p.
|
artikel
|
| 86 |
Prophylactic cranial irradiation in limited stage small cell lung cancer: Survival benefit in patients with favourable characteristics
|
|
|
1996
|
16 |
1 |
p. 126-
1 p.
|
artikel
|
| 87 |
Pulmonary thrombosis induced by anticancer chemotherapy in a patient with lung cancer
|
|
|
1996
|
16 |
1 |
p. 113-
1 p.
|
artikel
|
| 88 |
Purification and characterization of a protein that permits early detection of lung cancer: Identification of heterogeneous nuclear ribonucleoprotein- A2 B1 as the antigen for monoclonal antibody 703D4
|
|
|
1996
|
16 |
1 |
p. 109-110
2 p.
|
artikel
|
| 89 |
Quality of life and supportive care in the treatment of NSCLC
|
|
|
1996
|
16 |
1 |
p. 127-
1 p.
|
artikel
|
| 90 |
Radiation treatment of superior sulcus lung carcinoma
|
|
|
1996
|
16 |
1 |
p. 124-
1 p.
|
artikel
|
| 91 |
Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 118-
1 p.
|
artikel
|
| 92 |
Randomized study of NavelbineR and cisplatin versus vindesine and cisplatin versus NavelbineR alone in 612 patients with advanced non-small cell lung cancer (NSCLC)
|
|
|
1996
|
16 |
1 |
p. 120-
1 p.
|
artikel
|
| 93 |
Recent advances in lung cancer surgery in Europe
|
Motta, Giovanni
|
|
1996
|
16 |
1 |
p. 1-11
11 p.
|
artikel
|
| 94 |
Reply
|
Içli, Fikri
|
|
1996
|
16 |
1 |
p. 102-
1 p.
|
artikel
|
| 95 |
Results of surgical treatment of stage I and II lung cancer
|
|
|
1996
|
16 |
1 |
p. 118-
1 p.
|
artikel
|
| 96 |
Review of occupational lung carcinogens
|
|
|
1996
|
16 |
1 |
p. 105-
1 p.
|
artikel
|
| 97 |
Risk of lung cancer among former chromium smelter workers
|
|
|
1996
|
16 |
1 |
p. 106-107
2 p.
|
artikel
|
| 98 |
Roentgenographically occult small-cell lung cancer: Case report and review of the literature
|
|
|
1996
|
16 |
1 |
p. 115-
1 p.
|
artikel
|
| 99 |
Selective maternal-allele loss in human lung cancers of the maternally expressed p57(KIP2) gene at 11p15.5
|
|
|
1996
|
16 |
1 |
p. 110-
1 p.
|
artikel
|
| 100 |
Significance of IL-2R mRNA expression in patients with lung cancer
|
|
|
1996
|
16 |
1 |
p. 108-
1 p.
|
artikel
|
| 101 |
Small-cell carcinoma of the lung with paraneoplastic cerebellar degeneration
|
|
|
1996
|
16 |
1 |
p. 114-
1 p.
|
artikel
|
| 102 |
Small cell carcinoma of the pleura. A case report
|
Schinkewitch, Ph.
|
|
1996
|
16 |
1 |
p. 87-94
8 p.
|
artikel
|
| 103 |
Squamous cell carcinoma antigen (SccAg) in the diagnosis of lung cancer
|
|
|
1996
|
16 |
1 |
p. 113-
1 p.
|
artikel
|
| 104 |
Stability of p53 tumor suppressor gene mutations during the process of metastasis and during chemotherapy
|
|
|
1996
|
16 |
1 |
p. 121-
1 p.
|
artikel
|
| 105 |
Surgical experience in treating T4 lung cancer: Its resectability, morbidity, mortality and prognosis
|
|
|
1996
|
16 |
1 |
p. 119-
1 p.
|
artikel
|
| 106 |
Surgical resection of brain metastases from lung cancer
|
|
|
1996
|
16 |
1 |
p. 120-121
2 p.
|
artikel
|
| 107 |
Technique and results of bronchoplastic resections for non-small cell bronchial carcinoma
|
|
|
1996
|
16 |
1 |
p. 118-
1 p.
|
artikel
|
| 108 |
The impact of smoking habits on lung cancer risk: 28 years' observation of 26,000 Norwegian men and women
|
|
|
1996
|
16 |
1 |
p. 105-106
2 p.
|
artikel
|
| 109 |
The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 112-
1 p.
|
artikel
|
| 110 |
Therapeutic role of coagulation in small cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 123-
1 p.
|
artikel
|
| 111 |
The staging of lung cancer by bronchoscopic transbronchial needle aspiration
|
|
|
1996
|
16 |
1 |
p. 114-
1 p.
|
artikel
|
| 112 |
The susceptibility of human pulmonary adenocarcinoma cell treated with chemotherapeutic drugs to LAK cells
|
|
|
1996
|
16 |
1 |
p. 119-
1 p.
|
artikel
|
| 113 |
Time trends in lung-cancer mortality rates among men in Lithuania, 1965–1994
|
|
|
1996
|
16 |
1 |
p. 106-
1 p.
|
artikel
|
| 114 |
Treatment of metastatic non-small cell lung cancer
|
|
|
1996
|
16 |
1 |
p. 120-
1 p.
|
artikel
|
| 115 |
Treatment of small cell lung carcinoma in the elderly
|
|
|
1996
|
16 |
1 |
p. 127-
1 p.
|
artikel
|
| 116 |
Treatment of stage III–IV non-small-cell lung carcinoma with vinorelbine in combination with ifosfamide plus MESNA: A study by the Southern Italy Oncology Group (GOIM)
|
|
|
1996
|
16 |
1 |
p. 119-120
2 p.
|
artikel
|
| 117 |
Ultrasound-guided fine-needle aspiration biopsy of lung cancers
|
|
|
1996
|
16 |
1 |
p. 116-
1 p.
|
artikel
|
| 118 |
Verapamil (VPL) and/or tamoxifen (TAM) combined with chemotherapy in the treatment of refractory lung cancer
|
|
|
1996
|
16 |
1 |
p. 120-
1 p.
|
artikel
|
Tijdschrift beschrijving